GAP vs OGN · P/E 9.9, rev $15.09B vs P/E 3.4, rev $6.40B
The Gap, Inc. (GAP) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the GAP and OGN stock pages for the full models.
Not investment advice.